网站大量收购独家精品文档,联系QQ:2885784924

Comparison of Tazarotene and Minocycline Maintenance Therapies in Acne Vulgaris.pdf

Comparison of Tazarotene and Minocycline Maintenance Therapies in Acne Vulgaris.pdf

  1. 1、本文档共8页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Comparison of Tazarotene and Minocycline Maintenance Therapies in Acne Vulgaris

STUDY Comparison of Tazarotene and Minocycline Maintenance Therapies in Acne Vulgaris A Multicenter, Double-blind, Randomized, Parallel-Group Study James Leyden, MD; Diane M. Thiboutot, MD; Alan R. Shalita, MD; Guy Webster, MD, PhD; Kenneth Washenik, MD, PhD; Bruce E. Strober, MD, PhD; Jerome Shupack, MD Objective: To evaluate the efficacy of 3 maintenance regimens (topical tazarotene, oral minocycline hydro- chloride, or both) in sustaining improvement in acne. Design: Multicenter, open-label treatment phase fol- lowed by double-blind, randomized, parallel-group main- tenance phase. Setting: Ambulatory patients in research or referral centers. Patients: Volunteer sample of 189 patients with mod- erately severe to severe acne vulgaris (110 entered main- tenance phase, 90 completed, and 2 discontinued be- cause of adverse events). Interventions: All patients were treated with 0.1% taz- arotene gel (each evening) and a 100-mg capsule (twice daily) of minocycline hydrochloride for up to 12 weeks. Patients with 75% or greater global improvement at week 12 were randomly assigned to 12 weeks of maintenance therapy with tazarotene gel plus placebo capsules, vehicle gel plus minocycline capsules, or tazarotene gel plus minocycline capsules. Main Outcome Measures: Overall disease severity, global improvement, and lesion counts. Results: All regimens were effective in sustaining im- provements in acne. After 12 weeks of maintenance therapy, the mean reductions from baseline in nonin- flammatory and inflammatory lesion count, respec- tively, were 60% and 54% with tazarotene, 52% and 66% with minocycline, and 64% and 66% with tazarotene plus minocycline. At week 24, more than 80% of patients in each group had maintained a 50% or greater global im- provement from baseline, and more than 50% had main- tained a 75% or greater global improvement. Conclusions: A high percentage of patients with mod- erately severe to severe acne can maintain improvement in their condition with topic

文档评论(0)

l215322 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档